The key elements of an amino acid are carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), although other elements are found in the side chains of certain amino acids. Some amino acids derivatives are used in pharmaceutical industry. A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.
On the basis of product type, carglumic acid is expected to lead the market during the forecast period. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate over the course of the forecast period.
Global Amino Acid Metabolism Disorders Treatment market is segregated on the basis of indication as maple syrup urine disease, citrullinemia, homocystinuria. Based on product type, the global Amino Acid Metabolism Disorders Treatment market is segmented in folic acid, vitamin B6&b12, arginine, thiamine, vitamin D, betaine, sapropterin dihydrochloride, carglumic acid and others. The report also bifurcates global Amino Acid Metabolism Disorders Treatment market based on sales channel in hospital pharmacies, retail pharmacies and online sales.
Global Amino Acid Metabolism Disorders Treatment market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Amino Acid Metabolism Disorders Treatment market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
GlaxoSmithKline PLC, Merck KGaA, Sanofi are among the major players in the global Amino Acid Metabolism Disorders Treatment market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Amino Acid Metabolism Disorders Treatment Market has been segmented as below:
Amino Acid Metabolism Disorders Treatment Market, by Indication
Amino Acid Metabolism Disorders Treatment Market, by Product Type
Amino Acid Metabolism Disorders Treatment Market, by Sales Channel
Amino Acid Metabolism Disorders Treatment Market, By Region
The report covers:
Report scope:
Global Amino Acid Metabolism Disorders Treatment market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Amino Acid Metabolism Disorders Treatment market share. Major industry players with significant revenue share include Recordati S.p.A, Sanofi, Merck KGaA etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Technological advancements
4.2.2. Increasing chronic diseases
4.2.3. Increasing aging population
4.3. Restraints
4.3.1. High cost of products
5. Amino Acid Metabolism Disorders Treatment Market, By Indication
5.1. Key Points
5.2. Maple Syrup Urine Diseases
5.3. Citrullinemia
5.4. Homocystinuria
6. Amino Acid Metabolism Disorders Treatment Market, By Product Type
6.1. Key Points
6.2. Folic Acid
6.3. Vitamin B6 & B12
6.4. Arginine
6.5. Thiamine
6.6. Vitamin D
6.7. Betaine
6.8. Sapropterin Dihydrochloride
6.9. Carglumic Acid
6.10. Others
7. Amino Acid Metabolism Disorders Treatment Market, By Sales Channel
7.1. Key Points
7.2. Hospital Pharmacies
7.3. Retail Pharmacies
7.4. Online Sales
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Sanofi
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Merck KGaA
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. GlaxoSmithKline PLC
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Pfizer, Inc.
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Civentichem, LLC
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. AMINO GmbH
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
The Amino Acid Metabolism Disorders Treatment Market has been segmented as below:
Amino Acid Metabolism Disorders Treatment Market, by Indication
Amino Acid Metabolism Disorders Treatment Market, by Product Type
Amino Acid Metabolism Disorders Treatment Market, by Sales Channel
Amino Acid Metabolism Disorders Treatment Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
